loader
Please Wait
Applying Filters...

Information, Expiry & Status of Health Canada Patents covering Topotecan.

Menu
$ API Ref.Price (USD/KG) : 760,431Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2GlaxoSmithKline Inc.

02 1Blank

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass
Left Arrow
Right Arrow

01

arrow
Formnext Forum
Not Confirmed
arrow
Formnext Forum
Not Confirmed

Topotecan Hydrochloride

Brand Name : HYCAMTIN

Patent Number : 2103707

Filing Date : 1992-02-07

Strength per Unit : 4mg as free base per vial

Dosage Form : Sterile lyophilized Powder in single dose vials

Human Or VET : Human

Route of Administration : Intravenous Administration

Patent Expiration Date : 2012-02-07

Date Granted : 2003-12-09

blank

02

arrow
Formnext Forum
Not Confirmed
arrow
Formnext Forum
Not Confirmed

Topotecan Hydrochloride

Brand Name : HYCAMTIN

Patent Number : 2103708

Filing Date : 1992-02-07

Strength per Unit : 4mg as free base per vial

Dosage Form : Sterile lyophilized Powder in single dose vials

Human Or VET : Human

Route of Administration : Intravenous Administration

Patent Expiration Date : 2012-02-07

Date Granted : 2004-04-27

blank

03

arrow
Formnext Forum
Not Confirmed

Country
arrow
Formnext Forum
Not Confirmed

Topotecan Hydrochloride

Brand Name :

Patent Number : 1308102

Filing Date :

Strength per Unit :

Dosage Form :

Human Or VET :

Route of Administration :

Patent Expiration Date : 2009-09-29

Date Granted :

blank